Dakota Wealth Management Vertex Pharmaceuticals Inc Transaction History

Dakota Wealth Management

$4.35 Billion
Q3 2024

A detailed history of Dakota Wealth Management transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Dakota Wealth Management holds 34,393 shares of VRTX stock, worth $14 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

34,393

Previous 30,351 13.32%

Holding current value

$14 Million

Previous $14.2 Million 12.43%

% of portfolio

0.37%

Previous 0.34%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$460.0 - $505.78 $1.86 Million - $2.04 Million	4,042 Added 13.32%	34,393 $16 Million
Q2 2024 Jul 19, 2024	SELL	$392.81 - $485.53 $797,797 - $986,111	-2,031 Reduced 6.27%	30,351 $14.2 Million
Q1 2024 Apr 24, 2024	BUY	$407.69 - $446.08 $3.77 Million - $4.12 Million	9,240 Added 39.93%	32,382 $13.5 Million
Q4 2023 Jan 30, 2024	BUY	$343.0 - $410.68 $7.01 Million - $8.39 Million	20,427 Added 752.38%	23,142 $9.42 Million
Q3 2023 Oct 23, 2023	BUY	$338.18 - $362.46 $271,220 - $290,692	802 Added 41.92%	2,715 $944,000
Q2 2023 Jul 31, 2023	BUY	$314.42 - $351.91 $100,299 - $112,259	319 Added 20.01%	1,913 $673,000
Q1 2023 Apr 14, 2023	SELL	$283.23 - $323.1 $69,957 - $79,805	-247 Reduced 13.42%	1,594 $502,000
Q4 2022 Feb 07, 2023	SELL	$285.76 - $321.48 $135,736 - $152,703	-475 Reduced 20.51%	1,841 $531,000
Q3 2022 Nov 10, 2022	BUY	$273.83 - $305.53 $47,646 - $53,162	174 Added 8.12%	2,316 $670,000
Q2 2022 Aug 05, 2022	SELL	$234.96 - $292.55 $32,659 - $40,664	-139 Reduced 6.09%	2,142 $604,000
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $62,219 - $73,332	281 Added 14.05%	2,281 $595,000
Q1 2021 May 10, 2021	SELL	$207.02 - $241.31 $4,761 - $5,550	-23 Reduced 1.14%	2,000 $430,000
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $1,656 - $2,208	8 Added 0.4%	2,023 $478,000
Q3 2020 Nov 04, 2020	SELL	$255.65 - $303.1 $2.44 Million - $2.89 Million	-9,531 Reduced 82.55%	2,015 $548,000
Q2 2020 Aug 07, 2020	BUY	$225.48 - $295.8 $2.15 Million - $2.82 Million	9,546 Added 477.3%	11,546 $3.35 Million
Q1 2019 Apr 29, 2019	BUY	$163.73 - $194.7 $327,460 - $389,400	2,000 New	2,000 $368,000
Q1 2019 Apr 18, 2019	SELL	$163.73 - $194.7 $327,460 - $389,400	-2,000 Closed	0 $0
Q3 2017 Oct 16, 2017	BUY	$148.13 - $162.24 $296,260 - $324,480	2,000	2,000 $304,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dakota Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Dakota Wealth Management with notifications on news.

Account

Dakota Wealth Management Vertex Pharmaceuticals Inc Transaction History